In this study, we demonstrated that ERRα could play significant roles in the enhancement of tumorigenicity and stemness (in vitro anchorage-independent growth and enhanced expressions of CSCs-associated markers) of prostate cancer cells, regardless of their AR expression status, via its direct control of metabolic shift to be more OXPHOS-dependent and ATP-productive. The gene discussed is ESRRA; the disease is prostate carcinoma.